{"SPADE_N_03252": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_03252", "Peptide Name": "VmCT1", "Source": "Vaejovis mexicanus smithi (Scorpion)", "Family": "Belongs to the scorpion NDBP 5 family", "Gene": "Not found", "Sequence": "FLGALWNVAKSVF", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/I0DEB3"], "Protein Existence": "Transcript level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.27912176] Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=3.12 μmol/L), Bacillus subtilis ATCC 6633 (MIC=25μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.12μmol/L);Gram-negative bacterium:Pseudomonas aeruginosa ATCC 27853 (MIC=0.78μmol/L), Escherichia coli D31 (MIC=3.12μmol/L), Serratia marcescens ATCC 4112 (MIC=1.56μmol/L), Enterobacter cloacae β-12 (MIC=25μmol/L), Micrococcus luteus A270 (MIC=1.56μmol/L);Fungi:Candida albicans MDM8 (MIC=12.5μmol/L), Candida tropicalis IOC 4560 (MIC=6.25μmol/L), Candida parapsilosis IOC 4564 (MIC=25μmol/L), Aspergillus niger (MIC=25μmol/L), Cladosporium herbarum ATCC 26362 (MIC=50μmol/L), Cryptococcus neoformans (MIC=3.12μmol/L)", "Hemolytic Activity": "[Ref.27912176] 10% hemolysis at 1.99μmol/L against human red blood cells.", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "the peptide showed a coiled structure in water, zwitterionic lipid vesicles (POPC and POPC:DOPE) and negatively charge lipid vesicle (POPC:POPG) the analogs tend to adopt helical structures.", "Formula": "C72H106N16O16", "Mass": 1451.71, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": 1.21, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria, antifungal activity. Has hemolytic activity.", "Literature": [{"Title": "Novel designed VmCT1 analogs with increased antimicrobial activity", "Pubmed ID": "27912176", "Reference": "Eur J Med Chem. 2017 Jan 27;126456-463.", "Author": "Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27912176"}], "Frequent Amino Acids": "AFL", "Absent Amino Acids": "CDEHIMOPQRTUY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 7, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_13818", "Similarity": 1.0, "Sequence": "KRVNWRKVGRNTALGASYVLSFLG"}, {"SPADE_ID": "SPADE_UN_11711", "Similarity": 0.9230769230769231, "Sequence": "FLGALWKVAKSVF"}, {"SPADE_ID": "SPADE_UN_11712", "Similarity": 0.9230769230769231, "Sequence": "FLGALWNVAKKVF"}]}}}